Literature DB >> 18094116

Identification of 19 polymorphic major outer membrane protein genes and their immunogenic peptides in Ehrlichia ewingii for use in a serodiagnostic assay.

Chunbin Zhang1, Qingming Xiong, Takane Kikuchi, Yasuko Rikihisa.   

Abstract

Ehrlichia ewingii, a tick-transmitted rickettsia previously known only as a canine pathogen, was recently recognized as a human pathogen. E. ewingii has yet to be cultivated, and there is no serologic test available to diagnose E. ewingii infection. Previously, a fragment (505 bp) of a single E. ewingii gene homologous to 1 of 22 genes encoding Ehrlichia chaffeensis immunodominant major outer membrane proteins 1 (OMP-1s)/P28s was identified. The purposes of the present study were to (i) determine the E. ewingii omp-1 gene family, (ii) determine each OMP-1-specific peptide, and (iii) analyze all OMP-1 synthesized peptides for antigenicity. Using nested touchdown PCR and a primer walking strategy, we found 19 omp-1 paralogs in E. ewingii. These genes are arranged in tandem downstream of tr1 and upstream of secA in a 24-kb genomic region. Predicted molecular masses of the 19 mature E. ewingii OMP-1s range from 25.1 to 31.3 kDa, with isoelectric points of 5.03 to 9.80. Based on comparative sequence analyses among OMP-1s from E. ewingii and three other Ehrlichia spp., each E. ewingii OMP-1 oligopeptide that was predicted to be antigenic, bacterial surface exposed, unique in comparison to the other E. ewingii OMP-1s, and distinct from those of other Ehrlichia spp. was synthesized for use in an enzyme-linked immunosorbent assay. Plasmas from experimentally E. ewingii-infected dogs reacted significantly with most of the OMP-1-specific peptides, indicating that multiple OMP-1s were expressed and immunogenic in infected dogs. The results support the utility of the tailored OMP-1 peptides as E. ewingii serologic test antigens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094116      PMCID: PMC2268259          DOI: 10.1128/CVI.00366-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  52 in total

1.  Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents.

Authors:  A Unver; S Felek; C D Paddock; N Zhi; H W Horowitz; G P Wormser; L C Cullman; Y Rikihisa
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay.

Authors:  A A Gusa; R S Buller; G A Storch; M M Huycke; L J Machado; L N Slater; S L Stockham; R F Massung
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Transcriptional analysis of p30 major outer membrane multigene family of Ehrlichia canis in dogs, ticks, and cell culture at different temperatures.

Authors:  A Unver; N Ohashi; T Tajima; R W Stich; D Grover; Y Rikihisa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Evaluation of a polyvalent enzyme-linked immunosorbent assay incorporating a recombinant p44 antigen for diagnosis of granulocytic ehrlichiosis in dogs and horses.

Authors:  L A Magnarelli; J W Ijdo; A E Van Andel; C Wu; E Fikrig
Journal:  Am J Vet Res       Date:  2001-01       Impact factor: 1.156

5.  Analysis of transcriptionally active gene clusters of major outer membrane protein multigene family in Ehrlichia canis and E. chaffeensis.

Authors:  N Ohashi; Y Rikihisa; A Unver
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Population-based evaluation of the Ehrlichia ruminantium MAP 1B indirect ELISA.

Authors:  T F Peter; C J O'Callaghan; G F Medley; B D Perry; S M Semu; S M Maha
Journal:  Exp Appl Acarol       Date:  2001       Impact factor: 2.132

7.  Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization.

Authors:  Julia Shu-Yi Li; Frederick Chu; Andrew Reilly; Gary M Winslow
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  The omp-1 major outer membrane multigene family of Ehrlichia chaffeensis is differentially expressed in canine and tick hosts.

Authors:  Ahmet Unver; Yasuko Rikihisa; Roger W Stich; Norio Ohashi; Suleyman Felek
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 9.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus).

Authors:  Michael J Yabsley; Andrea S Varela; Cynthia M Tate; Vivien G Dugan; David E Stallknecht; Susan E Little; William R Davidson
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

View more
  4 in total

1.  Cloning of the major outer membrane protein expression locus in Anaplasma platys and seroreactivity of a species-specific antigen.

Authors:  Tzung-Huei Lai; Nelson G Orellana; Yumi Yuasa; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2011-04-15       Impact factor: 3.490

Review 2.  Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells.

Authors:  Yasuko Rikihisa
Journal:  Nat Rev Microbiol       Date:  2010-04-07       Impact factor: 60.633

3.  varDB: common ground for a shifting landscape.

Authors:  David R Allred; Anthony F Barbet; J David Barry; Kirk W Deitsch
Journal:  Trends Parasitol       Date:  2009-05-05

4.  Development of a Multiplex PCR and Magnetic DNA Capture Assay for Detecting Six Species Pathogens of the Genera Anaplasma and Ehrlichia in Canine, Bovine, Caprine and Ovine Blood Samples from Grenada, West Indies.

Authors:  Bhumika Sharma; Roman R Ganta; Diana Stone; Andy Alhassan; Marta Lanza-Perea; Vanessa Matthew Belmar; Inga Karasek; Elizabeth Cooksey; Catherine M Butler; Kathryn Gibson; Melinda J Wilkerson
Journal:  Pathogens       Date:  2021-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.